NOV 16, 2020 7:00 AM PST

Hepatitis B. The added value of an accurate diagnosis for the optimization of the patients clinical management

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor of Virology at the Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Italy
    BIOGRAPHY

Abstract

Date:  November 16, 2020

Time: 7:00am PDT

 

So far, it has been estimated that 2 billion individuals have been infected by hepatitis B virus (HBV). Among them, 250 million have developed a chronic infection and are at risk to develop cirrhosis and hepatocellular carcinoma. Every year, 1 million individuals die for these end-stage liver diseases. Nevertheless, these numbers are considered an underestimation and this is mainly due to the lack of adequate HBV screening programmes. Despite the availability of an effective vaccine, chronic HBV infection still remains an important driver of hepatocarcinogenesis. In endemic areas for HBV, 70-80% cases of liver cancer are caused by this virus.

In this light, the availability of an accurate armamentarium of HBV biomarkers is crucial for a proper diagnosis of HBV infection and in turn for a prompt retention in care of HBV infected patients pivotal slow down disease progression.

In this light, this webinar will be aimed at strengthening the importance of a proper and timely diagnosis of HBV infection, and at highlighting the role of classical and innovative biomarkers (such as quantitative serum HBsAg and quantitative serum HBeAg) in optimizing the management of patients with HBV infection.

 

Learning Objectives:

  • Strengthening the importance on an accurate HBV diagnosis for a prompt retention in care of patients with HBV infection 
  • Understanding the diagnostic and clinical relevance of HBV biomarkers 
  • Describing the clinical relevance of quantitative HBsAg and HBeAg

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
Loading Comments...
Show Resources